Form 4 · Filed Jul 1, 2026, 09:03 PM UTC
APTO/Aptose Biosciences Inc.
Vincent Mark D. — other
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
11 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | D | other | 50,000 | — | — | 0 |
| Jun 30, 2026 | D | other | 3,333 | — | — | 0 |
| Jun 30, 2026 | D | other | 100,000 | — | — | 0 |
| Jun 30, 2026 | D | other | 50,000 | — | — | 0 |
| Jun 30, 2026 | D | other | 50,000 | — | — | 0 |
| Jun 30, 2026 | D | other | 154,000 | — | — | 0 |
| Jun 30, 2026 | D | other | 40,000 | — | — | 0 |
| Jun 30, 2026 | D | other | 10,000 | — | — | 0 |
| Jun 30, 2026 | D | other | 5,000 | — | — | 0 |
| Jun 30, 2026 | D | other | 60,000 | — | — | 0 |
| Jun 13, 2026 | D | other | 14 | $2 | $24 | 0 |
Source: SEC EDGAR raw filing ↗ · Accession 0000912282-26-000898